These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 38963046

  • 1. Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells.
    Morino Y, Sugiyama H, Yamane K, Kikuchi M, Yamanaka T, Honda K, Monzen S.
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38963046
    [Abstract] [Full Text] [Related]

  • 2. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
    Wang Z, Zhang H, Dai L, Song T, Li P, Liu Y, Wang L.
    Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
    [Abstract] [Full Text] [Related]

  • 3. Peroxiredoxin 3 Has Important Roles on Arsenic Trioxide Induced Apoptosis in Human Acute Promyelocytic Leukemia Cell Line via Hyperoxidation of Mitochondrial Specific Reactive Oxygen Species.
    Mun YC, Ahn JY, Yoo ES, Lee KE, Nam EM, Huh J, Woo HA, Rhee SG, Seong CM.
    Mol Cells; 2020 Sep 30; 43(9):813-820. PubMed ID: 32975211
    [Abstract] [Full Text] [Related]

  • 4. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS, Kfoury Y, Darwiche N, Panjarian S, Kozhaya L, Nasr R, Abdallah M, Hermine O, El-Sabban M, de Thé H, Bazarbachi A.
    Haematologica; 2007 Jun 30; 92(6):753-62. PubMed ID: 17550847
    [Abstract] [Full Text] [Related]

  • 5. The cytotoxicity of arsenic trioxide to normal hematopoietic progenitors and leukemic cells is dependent on their cell-cycle status.
    Huang MJ, Hsieh RK, Lin CP, Chang IY, Liu HJ.
    Leuk Lymphoma; 2002 Nov 30; 43(11):2191-9. PubMed ID: 12533046
    [Abstract] [Full Text] [Related]

  • 6. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y.
    Clin Cancer Res; 2012 Dec 15; 18(24):6690-701. PubMed ID: 23082001
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R, Xia L, Gabrilove J, Waxman S, Jing Y.
    Leukemia; 2013 Feb 15; 27(2):315-24. PubMed ID: 22751450
    [Abstract] [Full Text] [Related]

  • 8. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
    Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A, Alimoghaddam K.
    Tumour Biol; 2012 Feb 15; 33(1):157-72. PubMed ID: 22072212
    [Abstract] [Full Text] [Related]

  • 9. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
    Guo Z, Meng M, Geng S, Du Z, Zheng Y, Yao J, Li Z, Han G, Lin H, Du G.
    J Ethnopharmacol; 2017 Jan 20; 196():29-38. PubMed ID: 27965050
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N, Yuan B, Hatta Y, Horikoshi A, Yoshino Y, Toyoda H, Aizawa S, Takeuchi J.
    Oncol Rep; 2012 Nov 20; 28(5):1875-82. PubMed ID: 22940758
    [Abstract] [Full Text] [Related]

  • 11. The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells.
    Cheng X, Quintás-Cardama A, Golemovic M, Zingaro R, Gao MZ, Freireich EJ, Andreeff M, Kantarjian HM, Verstovsek S.
    Anticancer Res; 2012 Jul 20; 32(7):2871-80. PubMed ID: 22753750
    [Abstract] [Full Text] [Related]

  • 12. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.
    Yedjou C, Tchounwou P, Jenkins J, McMurray R.
    J Hematol Oncol; 2010 Aug 26; 3():28. PubMed ID: 20796291
    [Abstract] [Full Text] [Related]

  • 13. Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).
    Hassani S, Khaleghian A, Ahmadian S, Alizadeh S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.
    Ann Hematol; 2018 Jan 26; 97(1):83-93. PubMed ID: 29159499
    [Abstract] [Full Text] [Related]

  • 14. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
    Hassani S, Ghaffari SH, Zaker F, Mirzaee R, Mardani H, Bashash D, Zekri A, Yousefi M, Zaghal A, Alimoghaddam K, Ghavamzadeh A.
    Ann Hematol; 2013 Sep 26; 92(9):1207-20. PubMed ID: 23645216
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Vivas-Mejía PE, Ozpolat B, Chen X, Lopez-Berestein G.
    Int J Cancer; 2009 Jul 15; 125(2):264-75. PubMed ID: 19408305
    [Abstract] [Full Text] [Related]

  • 16. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH.
    Leuk Res; 2014 Aug 15; 38(8):977-82. PubMed ID: 24953245
    [Abstract] [Full Text] [Related]

  • 17. Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia.
    Xu W, Li X, Quan L, Yao J, Mu G, Guo J, Wang Y.
    Leuk Lymphoma; 2018 Mar 15; 59(3):650-659. PubMed ID: 28679299
    [Abstract] [Full Text] [Related]

  • 18. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
    Noguera NI, Pelosi E, Angelini DF, Piredda ML, Guerrera G, Piras E, Battistini L, Massai L, Berardi A, Catalano G, Cicconi L, Castelli G, D'Angiò A, Pasquini L, Graziani G, Fioritoni G, Voso MT, Mastrangelo D, Testa U, Lo-Coco F.
    Oncotarget; 2017 May 16; 8(20):32550-32565. PubMed ID: 28427227
    [Abstract] [Full Text] [Related]

  • 19. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Ozpolat B, Akar U, Zorrilla-Calancha I, Vivas-Mejia P, Acevedo-Alvarez M, Lopez-Berestein G.
    Apoptosis; 2008 Jul 16; 13(7):915-28. PubMed ID: 18491231
    [Abstract] [Full Text] [Related]

  • 20. Interaction between arsenic trioxide and human primary cells: emphasis on human cells of myeloid origin.
    Binet F, Antoine F, Girard D.
    Inflamm Allergy Drug Targets; 2009 Mar 16; 8(1):21-7. PubMed ID: 19275690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.